Pieris Pharmaceuticals Inc is a clinical-stage biopharmaceutical company, which engages in the discovery and development of the Anticalin class of biotherapeutics.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Stephen S. Yoder$14.8M
Market Cap • 24/04/20242013
(há 11 anos)
2014
(10 years ago)
NASDAQ
Listagem
Boston
Sede • Massachusetts144
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
PIRSSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.